Investments – Page 7

This major investment demonstrates J&J’s commitment to expanding its U.S. manufacturing and innovation capabilities, with potential benefits for job creation and the domestic pharmaceutical industry. The announcement aligns with broader trends of increased U.S. manufacturing investment by large corporations in recent years.

Drugmakers renew concerns over UK’s attractiveness for investment

8 months ago talkbio0Tagged attractiveness, concerns, Industry, Investments, UK, UK 's

Investments, UK, UK ‘s, concerns, Industry, attractiveness

J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms

8 months ago talkbio0Tagged Carvykti, competition, Facility (object), Investments, J&J, Johnson and Johnson, Multiple Myeloma, production

Carvykti, Johnson and Johnson, Investments, J&J, Facility (object), Multiple Myeloma, production, competition

In an unusual move, Lilly seeks pitches from US states for slice of $27B buildout

8 months ago talkbio0Tagged Eli Lilly, Investments, Lilly 's, United States

Eli Lilly, Investments, United States, Lilly ‘s

Biotech Breakthroughs 2025: Emerging Trends and Technologies Shaping the Industry’s Future

9 months ago talkbio0Tagged Artificial Intelligence, Cancer Vaccines, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, Drug Discovery, Gene Modification, Investments, personalized therapies, Platform technologies, Precision Medicine, solid-state batteries

CRISPR therapeutics, solid-state batteries, precision medicine, AI in drug discovery, gene editing, cancer vaccines, personalized therapies, biotech investment, platform technologies, clinical trial innovation

Bain Capital Acquires Mitsubishi Tanabe Pharma for $3.3 Billion in Strategic Japanese Pharma Investment

9 months ago talkbio0Tagged Acquisition, Bain Capital, carve-out, Drug Industry, Investments, Japanese language, Mitsubishi, Private Equity, Transaction

Bain Capital, Mitsubishi Tanabe Pharma, acquisition, Japanese pharmaceutical industry, carve-out transaction, private equity, life sciences investment

AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction

9 months ago talkbio0Tagged Administration occupational activities, AstraZeneca, Drug Industry, Economic Growth, Government, Investments, Labor (Childbirth), Manufacturing, UK, Vaccines

AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry